Eli Lilly Provides 2013 Guidance

Don't let it get away!

Keep track of the stocks that matter to you.

Help yourself with the Fool's FREE and easy new watchlist service today.

Eli Lilly (NYSE: LLY  ) unveiled a set of expectations for its 2013 results, and reconfirmed its guidance for last year in an official statement. For the current fiscal year, the company believes it will post revenue of $22.6 billion-$23.4 billion, and non-GAAP earnings of $3.75-$3.90 per share. That compares favorably to analyst expectations, which averaged $22.9 billion and $3.72, respectively.

For 2012, the company stood by its previous assumptions of $3.30-$3.40 EPS.

That year, Lilly lost patent protection for Zyprexa, an anti-psychotic treatment that was its best-selling drug of all time. In 2013 the same will happen for its current number one, the anti-depressant drug Cymbalta.

The firm is to announce its 4Q and full-year 2012 results on January 29.

Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2180007, ~/Articles/ArticleHandler.aspx, 9/26/2016 1:23:24 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,130.27 -131.18 -0.72%
S&P 500 2,149.88 -14.81 -0.68%
NASD 5,265.62 -40.13 -0.76%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/26/2016 1:07 PM
LLY $79.98 Down -1.18 -1.45%
Eli Lilly and Co. CAPS Rating: ***